Korean Drug Co. Ltd (014570) — Free Cash Flow Generation Index
Korean Drug Co. Ltd (014570) has a Free Cash Flow Generation Index of 0.99x as of June 2026. Free cash flow of ₩1.89 Billion represents 1% of operating cash flow (₩1.90 Billion). Explore 014570 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Korean Drug Co. Ltd Free Cash Flow Generation Index (2014–2025)
Historical FCF Generation Index trend for Korean Drug Co. Ltd across 11 annual periods. For the full cash flow conversion analysis, see Korean Drug Co. Ltd cash flow conversion.
Annual Free Cash Flow Generation for Korean Drug Co. Ltd (2014–2025)
Year-by-year Free Cash Flow Generation Index for Korean Drug Co. Ltd. Check 014570 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.96x | ₩12.63 Billion | ₩13.11 Billion | ₩475.05 Million | ▲ +22.6% |
| 2024 | 0.79x | ₩3.83 Billion | ₩4.87 Billion | ₩1.04 Billion | ▲ +923.3% |
| 2022 | -0.10x | ₩-564.37 Million | ₩5.91 Billion | ₩6.09 Billion | ▼ -111.0% |
| 2021 | 0.87x | ₩7.65 Billion | ₩8.81 Billion | ₩1.15 Billion | ▼ -7.5% |
| 2020 | 0.94x | ₩11.57 Billion | ₩12.33 Billion | ₩738.47 Million | ▼ -37.1% |
| 2019 | 1.49x | ₩9.26 Billion | ₩6.21 Billion | ₩3.05 Billion | ▲ +21.8% |
| 2018 | 1.22x | ₩7.09 Billion | ₩5.79 Billion | ₩1.30 Billion | ▼ -65.3% |
| 2017 | 3.53x | ₩1.58 Billion | ₩447.20 Million | ₩1.13 Billion | ▲ +216.4% |
| 2016 | 1.12x | ₩4.42 Billion | ₩3.96 Billion | ₩460.84 Million | ▼ -2.4% |
| 2015 | 1.14x | ₩7.01 Billion | ₩6.13 Billion | ₩878.05 Million | ▲ +2.0% |
| 2014 | 1.12x | ₩5.00 Billion | ₩4.46 Billion | ₩538.19 Million | — |